DBH and Alzheimer disease: Decreases in DBH activity found in the early stages of AD may be a reflection of loss of noradrenergic (NA) neurons, and the treatment of early AD patients with selective NA reuptake inhibitors may be indicated in early stages of AD to compensate for loss of NA activities (Mustapic et al., 2013).